Mark de Boer
Hoogleraar
- Naam
- Prof. dr. M.G.J. de Boer MD
- Telefoon
- 071 5262613
- m.g.j.de_boer@lumc.nl
- ORCID iD
- 0000-0002-5009-6499
Hoogleraar
- Faculteit Geneeskunde
- LUMC
- Moes, D.J.A.R.; Westerloo, D.J. van; Arend, S.M.; Swen, J.J.; Vries, A. de; Guchelaar, H.J.; Joosten, S.A.; Boer, M.G.J. de; Gelder, T. van & Paassen, J. van (2022), Towards fixed dosing of tocilizumab in ICU-admitted COVID-19 patients, Clinical Pharmacokinetics 61.
- Verheul Marielle, Schonkeren-Ravensbergen Elizabeth, Bus Eva M., De Boer Mark G. J., Nelissen Rob G. H. H., Pijls Bart G. & Nibbering Peter H. (2026), Efficacy prediction of bacteriophage-antibiotic combinations against Staphylococcus aureus biofilms using planktonic bacteria, Frontiers in Microbiology 16.
- Leegwater, E.; Baidjoe, L.; Wilms, E.B.; Visser, L.G.; Touw, D.J.; Winter, B.C.M. de; Boer, M.G.J. de; Paassen, J. van; Berg, C.H.S.B. van den; Prehn, J. van; Gelder, T. van & Moes, D.J.A.R. (2025), Population pharmacokinetics of trimethoprim/sulfamethoxazole, Clinical Pharmacology & Therapeutics.
- Hanssen, J.L.J.; Linden, H.M.J. van der; Beek, M.T. van der; Wal, R.J.P. van der; Termaat, M.F.; Boer, M.G.J. de & Scheper, H. (2025), Implementation of multidisciplinary team decisions on the management of complex bone and joint infections, BMC Musculoskeletal Disorders 26(1).
- Sijbom, M.; Boelens, M.; Boer, M.G.J. de & Numans, M.E. (2025), Routine data registries as a basis to analyse and improve the quality of antimicrobial prescription in primary care, BMC Primary Care 26(1).
- Westgeest, A.C.; Hanssen, J.L.J.; Boer, M.G.J. de; Schippers, E.F. & Lambregts, M.M.C. (2025), Eradication of community-onset Methicillin-resistant Staphylococcus aureus carriage: a narrative review, Clinical Microbiology and Infection 31(2): 173-181.
- Hanssen Jaap L. J., van Hulten Esther Y., Bos Pieter K., van der Jagt Olav P., Lammers A. J. Jolanda, Mahdad Rachid, Nolte Peter A., Peters Edgar J. G., Poolman Rudolf W., Visser Jetze, Somford Matthijs P., Veerman Karin, Vehmeijer Stephan B. W., Vlasveld Imro N., Zijlstra Wierd, van Geenen Rutger, Geurts Jan, Roling Maarten, Wouthuyzen-Bakker Marjan, Scheper Henk & de Boer Mark G. J. (2025), Rifampicin combination therapy versus targeted antimicrobial monotherapy in the oral antimicrobial treatment phase of staphylococcal prosthetic joint infection (RiCOTTA-trial): protocol for a randomized, controlled, open-label, non-inferiority trial, Contemporary Clinical Trials 155.
- Medioli Filippo, Peiffer-Smadja Nathan, Catteau Lucy, Murri Rita, Schouten Jeroen A., Thursky Karin, de Boer Mark G. J. & Ashiru-Oredope Diane (2025), Enhancing antimicrobial stewardship: recommendations to support implementation of the 2024 UN General Assembly political declaration on antimicrobial resistance, Clinical Microbiology and Infection 31(9): 1427-1429.
- Meijden, S.L. van der; Boekel, A.M. van; Schinkelshoek, L.J.; Goor, H. van; Steyerberg, E.W.; Nelissen, R.G.H.H.; Mesotten, D.; Geerts, B.F.; Boer, M.G.J. de; Arbous, M.S. & PERISCOPE Grp (2025), Development and validation of artificial intelligence models for early detection of postoperative infections (PERISCOPE), The Lancet Regional Health Europe 49.
- Boekel, A.M. van; Meijden, S.L. van der; Geerts, B.F.; Goor, H. van; Geloven, N. van; Arbous, M.S.; Boer, M.G.J. de & PERISCOPE Study Grp (2025), C-reactive protein in the first 30 postoperative days and its discriminative value as a marker for postoperative infections, a multicentre cohort study, BMJ Open 15(4).
- Dun, S.C.J. van; Verheul, M.; Pijls, B.G.C.W.; Scheper, H.; Does, A.M. van der; Nibbering, P.H. & Boer, M.G.J. de (2025), Effectiveness of clindamycin-based exposure strategies in experimental mature staphylococcal biofilms, Microbiology Spectrum 13(3).
- Droogh, D.H.M.; Boer, M.G.J. de; Prehn, J. van; Putter, H.; Bonsing, B.A.; Bosscha, K.; Bouwense, S.A.W.; Braak, J.P.B.M.; Hoogwater, F.J.H.; Lips, D.J.; Luyer, M.D.P.; Stommel, M.W.J.; Wijsman, J.H.; Besselink, M.G.; Santvoort, H.C. van; Koerkamp, B.G.; Vahrmeijer, A.L. & Mieog, J.S.D. (2025), Standard versus pre-emptive antibiotic treatment to reduce the rate of infectious outcomes after Whipple resection (SPARROW), Trials 26(1).
- Kouijzer, I.J.E.; Ten Oever, J.; Hensgens, M.P.M.; Goorhuis, A.; Boer, M.G.J. de & Sigaloff, K.C.E. (2025), Gepersonaliseerde zorg bij Staphylococcus aureus-bacteriëmie, Nederlands Tijdschrift voor Geneeskunde 169.
- Verkaik, D.; Westgeest, A.C.; Wu, J.L.; Sigaloff, K.C.E.; Lambregts, M.M.C. & Boer, M.G.J. de (2025), Clinical revenues of selective use of [18F]-FDG-PET/CT scanning in the management of Staphylococcus aureus bacteremia, European Journal of Clinical Microbiology and Infectious Diseases 44.
- Dun, S.C.J. van; Knol, R.; Silva-Herdade, A.S.; Veiga, A.S.; Castanho, M.A.R.B.; Nibbering, P.H.; Pijls, B.G.C.W.; Does, A.M. van der; Dijkstra, J. & Boer, M.G.J. de (2025), Machine learning assisted classification of staphylococcal biofilm maturity, BIOFILM 9.
- Agtmaal, J.L. van; Verheul, M.; Vonken, L.; Helsen, K.; Guerrero, M.G.V.; Hoogstraten, S.W.G. van; Hurck, B.J.; Pilla, G.; Trinh, I.; Bruijn, G.J. de; Calum, H.P.; Boer, M.G.J. de; Pijls, B.G. & Arts, J.J.C. (2025), Antimicrobial resistance in orthopedics: microbial insights, clinical impact, and the necessity of a multidisciplinary approach-a review, Acta Orthopaedica 96: 555-568.
- Grootveld, R. van; Paassen, J. van; Claas, E.C.J.; Heerdink, L.; Kuijper, E.J.; Boer, M.G.J. de; Beek, M.T. van der & LUMC COVID 19 Res Grp (2024), Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, Medical Mycology 62(5).
- Hanssen, J.L.J.; Wal, R.J.P. van der; Mahdad, R.; Keizer, S.; Delfos, N.M.; Lugt, J.C.T. van der; Veldkamp, K.E.; Nolte, P.A.; Leendertse, M.; Gelinck, L.B.S.; Mollema, F.P.N.; Schippers, E.F.; Wattel-Louis, H.G.; Nelissen, R.G.H.H.; Scheper, H. & Boer, M.G.J. de (2024), Targeted antimicrobial regimens for Gram-negative prosthetic joint infections, Antimicrobial Agents and Chemotherapy 68(12).
- Brink, G. van den; Koggel, L.M.; Hendriks, J.J.H.; Boer, M.G.J. de; Siersema, P.D. & Numans, M.E. (2024), Treatment failure of Helicobacter pylori in primary care, British Journal of General Practice Open 8(3).
- Hanssen, J.L.J.; Gademan, M.G.J.; Wouthuyzen-Bakker, M.; Davis, J.S.; Dewar, D.; Manning, L.; Campbell, D.; Prehn, J. van; Miller, A.O.; Wal, R.J.P. van der; Linden, H.M.J. van der; Cortés-Penfield, N.W.; Soriano, A.; Boer, M.G.J. de & Scheper, H. (2024), Global practice variation of suppressive antimicrobial treatment for prosthetic joint infections, Journal of Infection 89(6).
- Swets, M.C.; Niessen, A.; Buddingh, E.P.; Vossen, A.C.T.M.; Veldkamp, K.E.; Veldhuijzen, I.K.; Boer, M.G. de & Groeneveld, G.H. (2024), Use of proxy indicators for automated surveillance of severe acute respiratory infection, the Netherlands, 2017 to 2023, Eurosurveillance: Europe's journal on infectious disease surveillance, epidemiology, prevention and control 29(27).
- Westgeest, A.C.; Lambregts, M.M.C.; Ruffin, F.; Korn, R.E.; Webster, M.E.; Kair, J.L.; Parsons, J.B.; Maskarinec, S.A.; Kaplan, S.; Dekkers, O.M.; Boer, M.G.J. de; Fowler, V.G. & Thaden, J.T. (2024), Female sex and mortality in patients with Staphylococcus aureus bacteremia, Jama Network Open 7(2).
- Meijgaarden, K.E. van; Veen, S. van; Tsonaka, R.; Ruibal, P.; Roukens, A.H.E.; Arbous, S.M.; Manniën, J.; Cannegieter, S.C.; Ottenhoff, T.H.M.; Joosten, S.A.; BEAT-COVID Grp & COVID-19 LUMC Grp (2024), Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease, Scientific Reports 14(1).
- Verheul, M.; Mulder, A.A.; Dun, S.C.J. van; Merabishvili, M.; Nelissen, R.G.H.H.; Boer, M.G.J. de; Pijls, B.G. & Nibbering, P.H. (2024), Bacteriophage ISP eliminates Staphylococcus aureus in planktonic phase, but not in the various stages of the biofilm cycle, Scientific Reports 14(1).
- Meijden, S.L. van der; Boekel, A.M. van; Goor, H. van; Nelissen, R.G.H.H.; Schoones, J.W.; Steyerberg, E.W.; Geerts, B.F.; Boer, M.G.J. de & Arbous, M.S. (2024), Automated Identification of Postoperative Infections to Allow Prediction and Surveillance Based on Electronic Health Record Data: Scoping Review, JMIR Medical Informatics 12.
- Eikenboom, A.M.; Lambregts, M.M.C.; Boer, M.G.J. de & Cessie, S. le (2024), Influence of initial misdiagnosis on mortality in patients with bacteraemia, BMC Infectious Diseases 24(1).
- Hanssen, J.L.J.; Wal, R.J.P. van der; Linden, H.M.J. van der; Prehn, J. van; Scheper, H. & Boer, M.G.J. de (2024), Dosing and treatment duration of suppressive antimicrobial therapy in orthopedic implant infections, Journal of Bone and Joint Infection 9(3): 149-159.
- Boekel, A.M. van; Meijden, S.L. van der; Arbous, S.M.; Nelissen, R.G.H.H.; Veldkamp, K.E.; Nieswaag, E.B.; Jochems, K.F.T.; Holtz, J.; Veenstra, A.v.I.; Reijman, J.; Jong, Y. de; Goor, H. van; Wiewel, M.A.; Schoones, J.W.; Geerts, B.F. & Boer, M.G.J. de (2024), Systematic evaluation of machine learning models for postoperative surgical site infection prediction, PLoS ONE 19(12).
- Klomp, S.D.; Veringa, A.; Alffenaar, J.W.C.; Boer, M.G.J. de; Span, L.F.R.; Guchelaar, H.J. & Swen, J.J. (2024), Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole, Clinical and Translational Science 17(7).
- Leegwater, E.; Dol, L.; Benard, M.R.; Roelofsen, E.E.; Delfos, N.M.; Feltz, M. van der; Mollema, F.P.N.; Bosma, L.B.E.; Visser, L.E.; Ottens, T.H.; Burgel, N.D. van; Arbous, S.M.; Bouazzaoui, L.H. el; Knevel, R.; Groenwold, R.H.H.; Boer, M.G.J. de; Visser, L.G.; Rosendaal, F.R.; Wilms, E.B. & Nieuwkoop, C. van (2023), Rapid response to remdesivir in hospitalised COVID-19 patients: A propensity score weighted multicentre cohort study, Infectious Diseases and Therapy 12(10): 2471-2484.
- Droogh, D.H.M.; Dam, J.L. van; Groen, J.V.; Boer, M.G.J. de; Prehn, J. van; Eijck, C.H.J. van; Bonsing, B.A.; Vahrmeijer, A.L.; Koerkamp, B.G. & Mieog, J.S.D. (2023), Prolonged antibiotics after pancreatoduodenectomy reduce abdominal infections in patients with positive bile cultures, HPB 25(9): 1056-1064.
- Wijnakker, R.; Maaren, M.S. van; Bode, L.G.M.; Bulatovic, M.; Hendriks, B.J.C.; Loogman, M.C.M.; Lutgens, S.P.M.; Middel, A.; Nieuwhof, C.M.G.; Roelofsen, E.E.; Schoones, J.W.; Sigaloff, K.C.E.; Sprikkelman, A.B.; Vrankrijker, L.M.M. de & Boer, M.G.J. de (2023), The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy, Clinical Microbiology and Infection 29(7): 863-875.
- Sijbom, M.; Büchner, F.L.; Saadah, N.H.; Numans, M.E. & Boer, M.G.J. de (2023), Determinants of inappropriate antibiotic prescription in primary care in developed countries with general practitioners as gatekeepers, BMJ Open 13(5).
- Westgeest, A.C.; Ruffin, F.; Kair, J.L.; Park, L.P.; Korn, R.E.; Webster, M.E.; Visser, L.G.; Schippers, E.F.; Boer, M.G.J. de; Lambregts, M.M.C. & Fowler, V.G. .J.r. (2023), The association of female sex with management and mortality in patients with Staphylococcus aureus bacteraemia, Clinical Microbiology and Infection 29(9): 1182-1187.
- Gerritsen, L.M.; Scheper, H.; Boer, M.G.J. de; Schoones, J.W.; Nelissen, R.G.H.H. & Pijls, B.G.C. (2023), Outcome of debridement, antibiotics and implant retention for streptococcal hip and knee prosthetic joint infections, SURGERY IN PRACTICE AND SCIENCE 14.
- Grootveld, R. van; Masarotto, V.; Borne, P.A. von dem; Blijlevens, N.M.A.; Chitu, D.A.; Beek, M.T. van der; Fiocco, M. & Boer, M.G.J. de (2023), Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome, BMC Infectious Diseases 23(1).
- Sijbom, M.; Buchner, F.L.; Saadah, N.H.; Numans, M.E. & Boer, M.G.J. de (2023), Trends in antibiotic selection pressure generated in primary care and their association with sentinel antimicrobial resistance patterns in Europe, Journal of Antimicrobial Chemotherapy 78(5).
- Brunink, E.M.; Hoogervorst, L.A.; Steentjes, K.; Broekhuis, D. & Boer, M.G.J. de (2023), Osteomyelitis caused by Streptococcus intermedius in immunocompetent adults - a case report and systematic literature review, European Journal of Clinical Microbiology and Infectious Diseases 42(9): 1055-1061.
- Veringa, A.; Bruggemann, R.J.; Span, L.F.R.; Biemond, B.J.; Boer, M.G.J. de; Heuvel, E.R. van den; Klein, S.K.; Kraemer, D.; Minnema, M.C.; Prakken, N.H.J.; Rijnders, B.J.A.; Swen, J.J.; Verweij, P.E.; Wondergem, M.J.; Ypma, P.F.; Blijlevens, N.; Kosterink, J.G.W.; Werf, T.S. van der; Alffenaar, J.W.C. & Voriconazole ZonMw Study Grp (2023), Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients, International Journal of Antimicrobial Agents 61(2).
- Droogh, D.H.M.; Groen, J.V.; Boer, M.G.J. de; Prehn, J. van; Putter, H.; Bonsing, B.A.; Eijck, C.H.J. van; Vahrmeijer, A.L.; Santvoort, H.C. van; Koerkamp, B.G. & Mieog, J.S.D. (2023), Prolonged antibiotic prophylaxis after pancreatoduodenectomy, British Journal of Surgery 110(11).
- Swets, M.C.; Moss, R.J.; Kor, F.; Hilarius, D.; Moes, D.J.A.R.; Berkhout, W.E.; Toorn, L.M. van den; Oever, N.C.G. van den; Valk, R. de; Rosendaal, F.R.; Hunfeld, N.; Groeneveld, G.H. & Boer, M.G.J. de (2023), A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19, International Journal of Infectious Diseases 129: 57-62.
- Dun, S.C.J. van; Verheul, M.; Pijls, B.G.C.W.; Prehn, J. van; Scheper, H.; Galli, F.; Nibbering, P.H. & Boer, M.G.J. de (2023), Influence of surface characteristics of implant materials on MRSA biofilm formation and effects of antimicrobial treatment, Frontiers in Microbiology 14.
- Westgeest, A.C.; Buis, D.T.P.; Sigaloff, K.C.E.; Ruffin, F.; Visser, L.G.; Yu, Y.S.; Schippers, E.F.; Lambregts, M.M.C.; Tong, S.Y.C.; Boer, M.G.J. de & Fowler, V.G. (2023), Global differences in the management of Staphylococcus aureus bacteremia, Clinical Infectious Diseases 77(8).
- Scheper, H.; Mahdad, R.; Elzer, B.; Löwik, C.; Zijlstra, W.; Gosens, T.; Lugt, J.C.T. van der; Wal, R.J.P. van der; Poolman, R.W.; Somford, M.P.; Jutte, P.C.; Bos, P.K.; Zwaan, R.E.; Nelissen, R.G.H.H.; Visser, L.G.; Boer, M.G.J. de & Wound Care App Study Grp (2023), Wound drainage after arthroplasty and prediction of acute prosthetic joint infection, Journal of Bone and Joint Infection 8(1): 59-70.
- Buis, D.T.P.; Werkhoven, C.H. van; Agtmael, M.A. van; Bax, H.I.; Berrevoets, M.; Boer, M.G.J. de; Bonten, M.J.M.; Bosmans, J.E.; Branger, J.; Douiyeb, S.; Gelinck, L.B.S.; Jong, E.; Lammers, A.J.J.; Meer, J.T.M. van der; Oosterheert, J.J.; Sieswerda, E.; Soetekouw, R.; Stalenhoef, J.E.; Vaart, T.W. van der; Vaate, E.A.B. de; Verkaik, N.J.; Vonderen, M.G.A. van; Vries, P.J. de; Prins, J.M.; Sigaloff, K.C.E. & Collaborators SAFE-Trial Study Grp (2023), Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial), BMJ Open 13(4).
- Welling, M.M.; Warbroek, K.; Khurshid, C.; Oosterom, M.N. van; Rietbergen, D.D.D.; Boer, M.G.J. de; Nelissen, R.G.H.H.; Leeuwen, F.W.B. van; Pijls, B.G. & Buckle, T. (2023), A radio- and fluorescently labelled tracer for imaging and quantification of bacterial infection on orthopaedic prostheses, Bone & Joint Research 12(1): 72-79.
- Popping, S.; Nichols, B.E.; Appelman, B.; Biemond, J.J.; Vergouwe, M.; Rosendaal, F.R.; Valk, M. van der; Bree, G.J. de; Wiersinga, W.J.; Birnie, E. & Turn-Covid Study Grp (2023), Health outcomes and cost-effectiveness of monoclonal SARS-CoV-2 antibodies as pre-exposure prophylaxis, Jama Network Open 6(7).
- Surial, B.; Mena, A.R.; Roumet, M.; Limacher, A.; Smit, C.; Leleux, O.; Mocroft, A.; Valk, M.V.; Bonnet, F.; Peters, L.; Rockstroh, J.K.; Guenthard, H.F.; Berzigotti, A.; Rauch, A. & Wandeler, G. (2023), External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection, Journal of Hepatology 78(5): 947-957.
- Eskenazi, A.; Lood, C.; Wubbolts, J.; Hites, M.; Balarjishvili, N.; Leshkasheli, L.; Askilashvili, L.; Kvachadze, L.; Noort, V. van; Wagemans, J.; Jayankura, M.; Chanishvili, N.; Boer, M. de; Nibbering, P.; Kutateladze, M.; Lavigne, R.; Merabishvili, M. & Pirnay, J.P. (2022), Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae, Nature Communications 13(1).
- Sijbom, M.; Braun, K.K.; Buchner, F.L.; Bodegom-Vos, L. van; Hendriks, B.J.C.; Boer, M.G.J. de; Numans, M.E. & Lambregts, M.M.C. (2022), Cues to improve antibiotic-allergy registration, PLoS ONE 17(4).
- Leuning, D.G.; Groeneveld, G.H.; Appelman, B.; Wiersinga, W.J. & Boer, M.G.J. de (2022), Significant impact of vaccination on length of hospital stay and survival in hospitalized patients with COVID-19.
- Scheper, H.; Wal, R.J.P. van der; Mahdad, R.; Keizer, S.; Delfos, N.M.; Lugt, J.C.T. van der; Veldkamp, K.E.; Nolte, P.A.; Leendertse, M.; Gelinck, L.B.S.; Mollema, F.P.N.; Schippers, E.F.; Wattel-Louis, H.G.; Visser, L.G.; Nelissen, R.G.H.H. & Boer, M.G.J. de (2022), Effectiveness of different antimicrobial strategies for staphylococcal prosthetic joint infection, Open Forum Infectious Diseases 9(10).
- Buis, D.T.P.; Prins, J.M.; Betica-Radic, L.; Boer, M.G.J. de; Ekkelenkamp, M.; Kofteridis, D.; Peiffer-Smadja, N.; Schouten, J.; Spernovasilis, N.; Tattevin, P.; Oever, J. ten; Sigaloff, K.C.E. & ESCMID Study Grp Antimicrobial Ste (2022), Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia, Journal of Antimicrobial Chemotherapy 77(10): 2827-2834.
- Westgeest, A.C.; Schippers, E.F.; Sijbom, M.; Visser, L.G.; Boer, M.G.J. de; Numans, M.E.; Lambregts, M.M.C. & MRSA Network Holland West (2022), Exploring the barriers in the uptake of the Dutch MRSA 'search and destroy' policy using the cascade of care approach, Antibiotics 11(9).
- Wymant, C.; Bezemer, D.; Blanquart, F.; Ferretti, L.; Gall, A.; Hall, M.; Golubchik, T.; Bakker, M.; Ong, S.H.; Zhao, L.; Bonsall, D.; Cesare, M. de; MacIntyre-Cockett, G.; Abeler-Dorner, L.; Albert, J.; Bannert, N.; Fellay, J.; Grabowski, M.K.; Gunsenheimer-Bartmeyer, B.; Gunthard, H.F.; Kivela, P.; Kouyos, R.D.; Laeyendecker, O.; Meyer, L.; Porter, K.; Ristola, M.; Sighem, A. van; Berkhout ben; Kellam, P.; Cornelissen, M.; Reiss, P.; Fraser, C.; Netherlands ATHENA HIV Observation & BEEHIVE Collaboration (2022), A highly virulent variant of HIV-1 circulating in the Netherlands, Science 375(6580): 540-+.
- Scheper, H. & Boer, M.G.J. de (2022), Rifampin for staphylococcal prosthetic joint infection: do we still need a randomized controlled trial?
- Eikenboom, A.M.; Cessie, S. le; Waernbaum, I.; Groenwold, R.H.H. & Boer, M.G.J. de (2022), Quality of conduct and reporting of propensity score methods in studies investigating the effectiveness of antimicrobial therapy, Open Forum Infectious Diseases 9(4).
- Westgeest, A.C.; Schippers, E.F.; Delfos, N.M.; Visser, L.G.; Fijter, J.W. de; Boer, M.G.J. de & Lambregts, M.M.C. (2022), Acute kidney injury in Staphylococcus aureus bacteremia, European Journal of Clinical Microbiology and Infectious Diseases 41.
- Roukens, A.H.E.; Pothast, C.R.; Konig, M.; Huisman, W.; Dalebout, T.; Tak, T.; Azimi, S.; Kruize, Y.; Hagedoorn, R.S.; Zlei, M.; Staal, F.J.T.; Bie, F.J. de; Dongen, J.J.M. van; Arbous, S.M.; Zhang, J.L.H.; Verheij, M.; Prins, C.; Does, A.M. van der; Hiemstra, P.S.; Vries, J.J.C. de; Janse, J.J.; Roestenberg, M.; Myeni, S.K.; Kikkert, M.; Yazdanbakhsh, M.; Heemskerk, M.H.M.; Smits, H.H.; Jochems, S.P.; Collaboration BEAT-COVID Grp & Collaboration COVID-19 LUMC Grp (2022), Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8(+) T cell responses following COVID-19, Nature Immunology 23.
- Smits, R.A.L.; Trompet, S.; Linden, C.M.J. van der; Bol, J.M. van der; Jansen, S.W.M.; Polinder-Bos, H.A.; Willems, H.C.; Barten, D.G.; Blomaard, L.C.; Boer, M.G.J. de; Deudekom, F.J.A. van; Ellerbroek, J.L.J.; Festen, J.; Glind, E.M.M. van de; Kampschreur, L.M.; Karimi, O.; Kroon, B.; Lanen, M.G.J.A. van; Lucke, J.A.; Maas, H.A.A.M.; Mattace-Raso, F.U.S.; Munster, B.C. van; Reijerse, L.; Robben, S.H.M.; Ruiter, R.; Schouten, H.J.; Spies, P.E.; Wassenburg, A.; Wijngaarden, M.A. & Mooijaart, S.P. (2022), Characteristics and outcomes of older patients hospitalised for COVID-19 in the first and second wave of the pandemic in The Netherlands, Age and Ageing 51(3).
- Sieswerda, E.; Bax, H.I.; Hoogerwerf, J.J.; Boer, M.G.J. de; Boermeester, M.; Bonten, M.J.M.; Dekker, D.; Wijk, R.G. van; Juffermans, N.P.; Kuindersma, M.; Linden, P.D. van der; Melles, D.C.; Pickkers, P.; Schouten, J.A.; Rebel, J.R.; Zanten, A.R.H. van; Prins, J.M. & Wiersinga, W.J. (2022), The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults, BMC Infectious Diseases 22(1).
- Sijbom, M.; Buechner, F.L.; Saadah, N.H.; Boer, M.G.D. & Numans, M.E. (2022), Comparing antibiotic prescriptions in primary care between SARS-CoV-2 and influenza, British Journal of General Practice Open 6(4).
- Hoogervorst, L.A.; Coul, L.S. op de; Ray, A.; Witte, P.B. de & Boer, M.G.J. de (2022), Mycetoma caused by Madurella mycetomatis in immunocompromised patients - a case report and systematic literature review, Journal of Bone and Joint Infection 7(6): 241-248.
- Hoogervorst, L.A.; Coul, L.S. op de; Ray, A.; Witte, P.B. de & Boer, M.G.J. de (2022), Mycetoma caused by Madurella mycetomatis in immunocompromised patients - a case report and systematic literature review, Journal of Bone and Joint Infection 7(6): 241-248.
- Boer, M. G. J. de; Bonten, M. J. M. & Huckriede, A. L. W. (2022), Een vooruitblik op covid-19-vaccinatie en -behandeling, Nederlands Tijdschrift voor Geneeskunde 166.
- Smit, J.M.; Krijthe, J.H.; Tintu, A.N.; Endeman, H.; Ludikhuize, J.; Genderen, M.E. van; Hassan, S.; Moussaoui, R. el; Westerweel, P.E.; Goekoop, R.J.; Waverijn, G.; Verheijen, T.; Hollander, J.G. den; Boer, M.G.J. de; Gommers, D.A.M.P.J.; Vlies, R. van der; Schellings, M.; Carels, R.A.; Nieuwkoop, C. van; Arbous, S.M.; Bommel, J. van; Knevel, R.; Rijke, Y.B. de & Reinders, M.J.T. (2022), Development and validation of an early warning model for hospitalized COVID-19 patientscohort study, Intensive Care Medicine Experimental 10(1).
- Slim, M.A.; Appelman, B.; Peters-Sengers, H.; Dongelmans, D.A.; Keizer, N.F. de; Schade, R.P.; Boer, M.G.J. de; Mueller, M.C.A.; Vlaar, A.P.J.; Wiersinga, W.J. & Vught, L.A. van (2022), Real-world evidence of the effects of novel treatments for COVID-19 on mortality, Open Forum Infectious Diseases 9(12).
- Berghuis, D.; Lambregts, M.M.C. & Boer, M.G.J. de (2021), Taking a Rational Approach to a Reported Antibiotic Allergy, The Pediatric Infectious Disease Journal 40(5): S22-S25.
- Westgeest, A.C.; Schippers, E.F.; Delfos, N.M.; Ellerbroek, L.J.; Koster, T.; Hira, V.; Visser, L.G.; Boer, M.G.J. de & Lambregts, M.M.C. (2021), Complicated carriage with methicillin-resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy 65(9).
- Gerritsen, M.; Khawar, A.; Scheper, H.; Wal, R. van der; Schoones, J.; Boer, M. de; Nelissen, R. & Pijls, B. (2021), Modular component exchange and outcome of DAIR for hip and knee periprosthetic joint infection A SYSTEMATIC REVIEW AND META-REGRESSION ANALYSIS, Bone & Joint Open 2(10): 806-812.
- Scheper, H.; Wubbolts, J.M.; Verhagen, J.A.M.; Visser, A.W. de; Wal, R.J.P. van der; Visser, L.G.; Boer, M.G.J. de & Nibbering, P.H. (2021), SAAP-148 eradicates MRSA persisters within mature biofilm models simulating prosthetic joint infection, Frontiers in Microbiology 12.
- Peppel, R.J. van de; Grootveld, R. van; Hendriks, B.J.C.; Paassen, J. van; Bernards, S.; Jolink, H.; Koopmans, J.G.; Borne, P.A. von dem; Beek, M.T. van der & Boer, M.G.J. de (2021), Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance, Medical Mycology 60(1).
- Scheper, H.; Gerritsen, L.M.; Pijls, B.G.; Asten, S.A. van; Visser, L.G. & Boer, M.G.J. de (2021), Outcome of debridement, antibiotics, and implant retention for staphylococcal hip and knee prosthetic joint infections, focused on rifampicin use: a systematic review and meta-analysis, Open Forum Infectious Diseases 8(7).
- Smit, C.; Boyd, A.; Rijnders, B.J.A.; Laar, T.J.W. van de; Leyten, E.M.; Bierman, W.F.; Brinkman, K.; Claassen, M.A.A.; Hollander, J. den; Boerekamps, A.; Newsum, A.M.; Schinkel, J.; Prins, M.; Arends, J.E.; Coul, E.L.M. op de; Valk, M. van der; Reiss, P. & ATHENA Observational Cohort (2021), HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals, The Lancet HIV 8(2): E96-E105.
- Lambregts, M.; Rump, B.; Ropers, F.; Sijbom, M.; Petrignani, M.; Visser, L.; Vries, M. de & Boer, M. de (2021), Antimicrobial guidelines in clinical practice, JAC-Antimicrobial Resistance 3(2).
- Groen, J.V.; Droogh, D.H.M.; Boer, M.G.J. de; Asten, S.A.V. van; Prehn, J. van; Inderson, A.; Vahrmeijer, A.L.; Bonsing, B.A. & Mieog, J.S.D. (2021), Clinical implications of bile cultures obtained during pancreatoduodenectomy, HPB 23(7): 1123-1133.
- Peppel, R.J. van de; Grootveld, R. van; Hendriks, B.J.C.; Paassen, J. van; Bernards, S.; Jolink, H.; Koopmans, J.G.; Borne, P.A. von dem; Beek, M.T. van der & Boer, M.G.J. de (2021), Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance, Medical Mycology 60(1).
- Grootveld, R. van; Paassen, J. van; Boer, M.G.J. de; Claas, E.C.J.; Kuijper, E.J.; Beek, M.T. van der & LUMC-COVID-19 Research Grp (2021), Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate, Mycoses 64(6).
- Sieswerda, E.; Boer, M.G.J. de; Bonten, M.M.J.; Boersma, W.G.; Jonkers, R.E.; Aleva, R.M.; Kullberg, B.J.; Schouten, J.A.; Garde, E.M.W. van de; Verheij, T.J.; Eerden, M.M. van der; Prins, J.M. & Wiersinga, W.J. (2021), Recommendations for antibacterial therapy in adults with COVID-19-an evidence based guideline, Clinical Microbiology and Infection 27(1): 61-66.
- Laar, S.A. van; Boer, M.G.J. de; Gombert-Handoko, K.B.; Guchelaar, H.J.; Zwaveling, J. & LUMC-Covid-19 Res grp (2021), Liver and kidney function in patients with Covid-19 treated with remdesivir, British Journal of Clinical Pharmacology 87(11).
- Boer, M. G. J. de (2021), Antibioticakuur korter door procalcitonine-algoritme, Nederlands Tijdschrift voor Geneeskunde 166.
- Lambregts, M.M.C.; Wijnakker, R.; Bernards, A.T.; Visser, L.G.; Cessie, S. le & Boer, M.G.J. de (2020), Mortality after delay of adequate empiric antimicrobial treatment of bloodstream infection, Journal of Clinical Medicine 9(5).
- Wijnakker, R.; Lambregts, M.M.C.; Rump, B.; Veldkamp, K.E.; Reis, R.; Visser, L.G. & Boer, M.G.J. de (2020), Limited multi-drug resistant organism related stigma in carriers exposed to isolation precautions, Journal of Hospital Infection 106(1): 126-133.
- Groeneveld, G.H.; Marbus, S.D.; Ismail, N.; Vries, J.J. de; Schneeberger, P.; Oosterheert, J.J.; Dissel, J.T. van & Boer, M.G.J. de (2020), Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection, International Journal of Antimicrobial Agents 56(5).
- Overbosch, F.; Boer, M. de; Veldkamp, K.E.; Ellerbroek, P.; Bleeker-Rovers, C.P.; Goorhuis, B.; Vugt, M. van; Eijk, A. van der; Leenstra, T.; Khargi, M.; Ros, J.; Brandwagt, D.; Haverkate, M.; Swaan, C.; Reusken, C.; Timen, A.; Koopmans, M.; Dissel, J. van & Lassa Fever Response Team Netherla (2020), Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019, Eurosurveillance 25(15): 6-10.
- Chen, Q.G.; Toorop, M.M.A.; Boer, M.G.J. de; Rosendaal, F.R.; Lijfering, W.M. & LUMC-COVID-19 Res Grp (2020), Why crowding matters in the time of COVID-19 pandemic? , BMC Public Health 20(1).
- Visbeek, M.C.; Taljaard, J.J.; Boer, M.G.J. de; Cronje, U.J. & Steyn, E. (2020), Efficacy and patterns of use of antimicrobial prophylaxis for gunshot wounds in a South African hospital setting, South African Journal of Surgery 58(1): 27-32.
- Peppel, R.J. van de; Schauwvlieghe, A.; Daele, R. van; Spriet, I.; van't Wout, J.W.; Bruggemann, R.J.; Rijnders, B.J.A.; Hendriks, B.J.C.; Boer, M.G.J. de & Dutch-Belgian Mycosis Study Grp (2020), Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B, Medical Mycology 58(7): 874-880.
- Lambregts, M.M.C. & Boer, M.G.J. de (2020), Preoperative oral antibiotics in colon surgery.
- Dijk, S.T. van; Abdulrahman, N.; Draaisma, W.A.; Enst, W.A. van; Puylaert, J.B.C.M.; Boer, M.G.J. de; Klarenbeek, B.R.; Otte, J.A.; Felt-Bersma, R.J.F.; Geloven, A.A.W. van & Boermeester, M.A. (2020), A systematic review and meta-analysis of disease severity and risk of recurrence in young versus elderly patients with left-sided acute diverticulitis, European Journal of Gastroenterology & Hepatology 32(5): 547-554.
- Lambregts, M.M.C.; Molendijk, E.B.D.; Meziyerh, S.; Schippers, E.F.; Delfos, N.M.; Leendertse, M.; Bernards, A.T.; Visser, L.G.; Dekkers, O.M. & Boer, M.G.J. de (2020), Early differentiation between uncomplicated and complicatedStaphylococcus aureusbacteraemia, International Journal of Clinical Practice 74(11).
- Wijnakker, R.; Lambregts, M.M.C.; Rump, B.; Veldkamp, K.E.; Reis, R.; Visser, L.G. & Boer, M.G.J. de (2020), Limited multi-drug resistant organism related stigma in carriers exposed to isolation precautions, Journal of Hospital Infection 106(1): 126-133.
- Boer, M. G. J. de; Gieling, E. M.; Linden, P. D. van der; Sinha, B. N. M. & Vollaard, A. M. (2020), Medicamenteuze behandeling van COVID-19, Nederlands Tijdschrift voor Geneeskunde 164.
- Vollaard, A.; Gieling, E. M.; Linden, P. D. van der; Sinha, B. & Boer, M. G. J. de (2020), Hydroxychloroquine en chloroquine bij COVID-19, Nederlands Tijdschrift voor Geneeskunde 164.
- Lambregts, M. M.; Hendriks, B. J.; Sijbom, M.; Sigaloff, K.; Nieuwhof, C. & Boer, M. G. de (2020), Kruisallergie van penicillines met cefalosporines, Nederlands Tijdschrift voor Geneeskunde 164.
- Chen, Q.G.; Toorop, M.M.A.; Boer, M.G.J. de; Rosendaal, F.R.; Lijfering, W.M. & LUMC-COVID-19 Res Grp (2020), Why crowding matters in the time of COVID-19 pandemic?, BMC Public Health 20(1).
- Lambregts, M.M.C.; Molendijk, E.B.D.; Meziyerh, S.; Schippers, E.F.; Delfos, N.M.; Leendertse, M.; Bernards, A.T.; Visser, L.G.; Dekkers, O.M. & Boer, M.G.J. de (2020), Early differentiation between uncomplicated and complicated Staphylococcus aureus bacteraemia, International Journal of Clinical Practice 74(11).
- Lambregts, M.M.C.; Visser, L.G.; Boer, M.G.J. de; Staats, H. & Dijk, E. van (2019), 'Determinants of in-hospital antibiotic prescription behaviour' - Author's reply, Clinical Microbiology and Infection 25(5): 638-639.
- Warreman, E.B.; Lambregts, M.M.C.; Wouters, R.H.P.; Visser, L.G.; Staats, H.; Dijk, E. van & Boer, M.G.J. de (2019), Determinants of in-hospital antibiotic prescription behaviour: a systematic review and formation of a comprehensive framework, Clinical Microbiology and Infection 25(5): 538-545.
- Jonge, E. de; Boer, M.G.J. de; Essen, E.H.R. van; Dogterom-Ballering, H.C.M. & Veldkamp, K.E. (2019), Effects of a disinfection device on colonization of sink drains and patients during a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Journal of Hospital Infection 102(1): 70-74.
- Rottier, S.J.; Dijk, S.T. van; Geloven, A.A.W. van; Schreurs, W.H.; Draaisma, W.A.; Enst, W.A. van; Puylaert, J.B.C.M.; Boer, M.G.J. de; Klarenbeek, B.R.; Otte, J.A.; Felt, R.J.F. & Boermeester, M.A. (2019), Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis, British Journal of Surgery 106(8): 988-997.
- Sanders, P.T.J.; Bus, M.P.A.; Scheper, H.; Wal, R.J.P. van der; Sande, M.A.J. van de; Bramer, J.A.M.; Schaap, G.R.; Boer, M.G.J. de & Dijkstra, P.D.S. (2019), Multiflora and Gram-Negative Microorganisms Predominate in Infections Affecting Pelvic Endoprostheses Following Tumor Resection, Journal of Bone and Joint Surgery, American Volume 101(9): 797-803.
- Lambregts, M.M.C.; Bernards, A.T.; Beek, M.T. van der; Visser, L.G. & Boer, M.G. de (2019), Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy, PLoS ONE 14(1).
- Lambregts, M.M.C.; Hendriks, B.J.C.; Visser, L.G.; Bernards, S.T. & Boer, M.G.J. de (2019), Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study, Antimicrobial Resistance and Infection Control 8.
- Peppel, R.J. van de; Beek, M.T. van der; Visser, L.G.; Boer, M.G.J. de & Wallinga, J. (2019), Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies, International Journal of Antimicrobial Agents 53(3): 284-293.
- Zoest, R.A. van; Law, M.; Sabin, C.A.; Vaartjes, I.; Valk, M. van der; Arends, J.E.; Reiss, P.; Wit, F.W.; Geerlings, S.E.; Godfried, M.H.; Goorhuis, A.; Hovius, J.W.; Kuijpers, T.W.; Nellen, F.J.B.; Poll, D.T. van der; Prins, J.M.; Vugt, H.J.M. van; Wiersinga, W.J.; Wit, F.W.M.N.; Duinen, M. van; Eden, J. van; Hes, A.M.H. van; Pijnappel, F.J.J.; Weijsenfeld, A.M.; Jurriaans, S.; Back, N.K.T.; Zaaijer, H.L.; Berkhout, B.; Cornelissen, M.T.E.; Schinkel, C.J.; Wolthers, K.C.; Peters, E.J.G.; Agtmael, M.A. van; Bomers, M.; Heitmuller, M.; Laan, L.M.; Ang, C.W.; Houdt, R. van; Pettersson, A.M.; Vandenbroucke-Grauls, C.M.J.E.; Berge, M. van den; Stegeman, A.; Baas, S.; Looff, L.H. de; Wintermans, B.; Veenemans, J.; Pronk, M.J.H.; Ammerlaan, H.S.M.; Munnik, E.S. de; Jansz, A.R.; Tjhie, J.; Wegdam, M.C.A.; Deiman, B.; Scharnhorst, V.; Eeden, A. van; Brokking, W.; Groot, M.; Elsenburg, L.J.M.; Damen, M.; Kwa, I.S.; Kasteren, M.E.E. van; Brouwer, A.E.; Erve, R. van; Kruijf-van de Wiel, B.A.F.M. de; Ven, B. van de; Buiting, A.G.M.; Kabel, P.J.; Versteeg, D.; Ende, M.E. van der; Bax, H.I.; Gorp, E.C.M. van; Nouwen, J.L.; Rijnders, B.J.A.; Schurink, C.A.M.; Verbon, A.; Vries-Sluijs, T.E.M.S. de; Jong-Peltenburg, N.C. de; Bassant, N.; Beek, J.E.A. van; Vriesde, M.; Zonneveld, L.M. van; Berg-Cameron, H.J. van den; Groot, J. de; Zeeuw-de Man, M. de; Boucher, C.A.B.; Koopmans, M.P.G.; Kampen, J.J.A. van; Pas, S.D.; Branger, J.; Douma, R.A.; Duijf-van de Ven, C.J.H.M.; Schippers, E.F.; Nieuwkoop, C. van; IJperen, J.M. van; Geilings, J.; Hut, G. van der; Burgel, N.D. van; Leyten, E.M.S.; Gelinck, L.B.S.; Davids-Veldhuis, S.; Hartingsveld, A.Y. van; Meerkerk, C.; Wildenbeest, G.S.; Heikens, E.; Groeneveld, P.H.P.; Bouwhuis, J.W.; Lammers, A.J.J.; Kraan, S.; Hulzen, A.G.W. van; Kruiper, M.S.M.; Bliek, G.L. van der; Bor, P.C.J.; Bloembergen, P.; Wolfhagen, M.J.H.M.; Ruijs, G.J.H.M.; Kroon, F.P.; Boer, M.G.J. de; Scheper, H.; Jolink, H.; Dorama, W.; Holten, N. van; Claas, E.C.J.; Wessels, E.; Hollander, J.G. den; Pogany, K.; Roukens, A.; Kastelijns, M.; Smit, J.V.; Smit, E.; Struik-Kalkman, D.; Tearno, C.; Niekerk, T. van; Pontesilli, O.; Lowe, S.H.; Lashof, A.M.L.O.; Posthouwer, D.; Ackens, R.P.; Burgers, K.; Schippers, J.; Weijenberg-Maes, B.; Loo, I.H.M. van; Havenith, T.R.A.; Mulder, J.W.; Vrouenraets, S.M.E.; Lauw, F.N.; Broekhuizen, M.C. van; Vlasblom, D.J.; Smits, P.H.M.; Weijer, S.; Moussaoui, R. el; Bosma, A.S.; Vonderen, M.G.A. van; Kampschreur, L.M.; Dijkstra, K.; Faber, S.; Weel, J.; Kootstra, G.J.; Delsing, C.E.; Burg-van de Plas, M. van der; Heins, H.; Kortmann, W.; Twillert, G. van; Renckens, R.; Ruiter-Pronk, D.; Truijen-Oud, F.A. van; Stuart, J.W.T.C.; IJzerman, E.P.; Jansen, R.; Rozemeijer; Reijden, W.A. van der; Brinkman, K.; Berk, G.E.L. van den; Blok, W.L.; Frissen, P.H.J.; Lettinga, K.D.; Schouten, W.E.M.; Veenstra, J.; Brouwer, C.J.; Geerders, G.F.; Hoeksema, K.; Kleene, M.J.; Meche, I.B. van der; Spelbrink, M.; Toonen, A.J.M.; Wijnands, S.; Kwa, D.; Regez, R.; Crevel, R. van; Keuter, M.; Ven, A.J.A.M. van der; Hofstede, H.J.M. ter; Dofferhoff, A.S.M.; Hoogerwerf, J.; Grintjes-Huisman, K.J.T.; Haan, M. de; Marneef, M.; Rahamat-Langendoen, J.; Stelma, F.F.; Burger, D.; Gisolf, E.H.; Hassing, R.J.; Claassen, M.; Beest, G. ter; Bentum, P.H.M. van; Langebeek, N.; Tiemessen, R.; Swanink, C.M.A.; Lelyveld, S.F.L. van; Soetekouw, R.; Prijt, L.M.M. van der; Swaluw, J. van der; Bermon, N.; Reijden, W.A. van der; Jansen, R.; Herpers, B.L.; Veenendaal, D.; Verhagen, D.W.M.; Wijk, M. van; Bierman, W.F.W.; Bakker, M.; Kleinnijenhuis, J.; Kloeze, E.; Stienstra, Y.; Wilting, K.R.; Wouthuyzen-Bakker, M.; Boonstra, A.; Meulen, P.A. van der; Weerd, D.A. de; Niesters, H.G.M.; Leer-Buter, C.C. van; Knoester, M.; Hoepelman, A.I.M.; Barth, R.E.; Bruns, A.H.W.; Ellerbroek, P.M.; Mudrikova, T.; Oosterheert, J.J.; Schadd, E.M.; Wassenberg, M.W.M.; Zoelen, M.A.D. van; Aarsman, K. & Elst-Laurijssen, D.H. (2019), Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV, Journal of Acquired Immune Deficiency Syndromes 81(5): 562-571.
- Peppel, R.J. van de & Boer, M.G.J. de (2019), The Complex Case of Aspergillus and Mortality, Clinical Infectious Diseases 68(3): 531-532.
- Newsum, A.M.; Kooij, K.W.; Boyd, A.; Smit, C.; Wit, F.W.N.M.; Meer, J.T.M. van der; Prins, M.; Reiss, P.; Valk, M. van der; Eden, H. van; Molenkamp, R.; Pijnappel, F.; Reesink, H.W.; Schinkel, J.; Steba, G.S.; Berk, G.E.L. van den; Brinkman, K.; Hooijenga, I.; Kwa, D.; Meche, N. van der; Toonen, A.; Vos, D.; Broekhuizen, M. van; Lauw, E.N.; Mulder, J.W.; Arend, J.E.; Kessel, A. van; Silvius, B.; Versloot, M.; Boonstra, A.; Rijnders, B.J.A.; Brokking, W.; Eeden, A. van; Elsenburg, L.; Nobel, H.E.; Laar, T.J.W. van de; Veldt, W. van der; Geerlings, S.E.; Goorhuis, A.; Hovius, J.W.; Lempkes, B.; Nellen, F.J.B.; Poll, T. van der; Prins, J.M.; Vugt, M. van; Wiersinga, W.J.; Duinen, M. van; Eden, J. van; Hazenberg, A.; Hes, A.M.H. van; Pijnappel, F.J.J.; Smalhout, S.Y.; Weijsenfeld, A.M.; Jurriaans, S.; Back, N.K.T.; Zaaijer, H.L.; Berkhout, B.; Cornelissen, M.T.E.; Schinkel, C.J.; Wolthers, K.C.; Peters, E.J.G.; Agtmael, M.A. van; Bomers, M.; Sigaloff, K.C.E.; Heitmuller, M.; Laan, L.M.; Ang, C.W.; Houdt, R. van; Jonges, M.; Pettersson, A.M.; Prehn, J. van; Berge, M. van den; Stegeman, A.; Baas, S.; Looff, L.H. de; Wintermans, B.; Veenemans, J.; Pronk, M.J.H.; Ammerloan, H.S.M.; Munnik, E.S. de; Jansz, A.R.; Tjhie, J.; Wegdam, M.C.A.; Deiman, B.; Scharnhorst, V.; Elsenburg, L.J.M.; Nobel, H.; Damen, M.; Kasteren, M.E.E. van; Berrevoets, M.A.H.; Brouwer, A.E.; Adams, A.; Kruijf-van de Wiel, B.A.E. de; Keelan-Pfaf, S.; Ven, B. van de; Ven, B. van der; Buiting, A.G.M.; Murck, J.L.; Versteeg, D.; Ende, M.E. van der; Box, H.I.; Gorp, E.C.M. van; Nouwen, J.L.; Schurink, C.A.M.; Verbon, A.; Vries-Sluijs, T.E.M.S. de; Jong-Peltenburg, N.C. de; Bassant, N.; Beek, J.E.A. van; Vriesde, M.; Zonneveld, L.M. van; Berg-Cameron, H.J. van den; Groot, J. de; Boucher, C.A.B.; Koopmans, M.P.G.; Kampen, J.J.A. van; Branger, J.; Douma, R.A.; Duijf-van de Ven, C.J.H.M.; Schippers, E.F.; Nieuwkoop, C. van; IJperen, J.M. van; Geilings, J.; Hut, G. van der; Burgel, N.D. van; Leyten, E.M.S.; Gelinck, L.B.S.; Mollema, F.; Davids-Veldhuis, S.; Hartingsveld, A.Y. van; Wildenbeest, G.S.; Heikens, E.; Groeneveld, P.H.P.; Bouwhuis, J.W.; Lammers, A.J.J.; Kraan, S.; Hulzen, A.G.W. van; Kruiper, M.S.M.; Bliek, G.L. van der; Bor, P.C.J.; Bloembergen, P.; Wolthagen, M.H.M.; Ruijs, G.J.H.M.; Kroon, E.; Boer, M.G.J. de; Scheper, H.; Jolink, H.; Dorama, W.; Holten, N. van; Claas, E.C.J.; Wessels, E.; Hollander, J.G. den; Pogany, K.; Roukens, A.; Douma, R.; Kastelijns, M.; Smit, J.V.; Smit, E.; Struik-Kalkman, D.; Tearno, C.; Niekerk, T. van; Pontesilli, O.; Lowe, S.H.; Lashof, A.M.L.O.; Posthouwer, D.; Ackens, R.P.; Burgers, K.; Schippers, J.; Enberg-Maes, B.W.; Loo, I.H.M. van; Havenith, T.R.A.; Vrouenraets, S.M.E.; Broekhuizen, M.C. van; Vlasblom, D.J.; Kroeze, M.; Smits, P.H.M.; Weijer, S.; Moussaoui, R. el; Bosma, A.S.; Vonderen, M.G.A. van; Kampschreur, L.M.; Faber, S.; Steeman-Bouma, R.; Wed, J.; Kootstra, G.J.; Delsing, C.E.; Burg-van de Plas, M. van der; Heins, H.; Kortmann, W.; Twillert, G. van; Renckens, R.; Ruiter-Pronk, D.; Truijen-Oud, E.A. van; Stuart, J.W.T.C.; Jansen, E.R.; Hoogewerf, M.; Rozemeijer, W.; Reijden, W.A. van der; Sinnige, J.C.; Blok, W.L.; Frissen, P.H.J.; Lettinga, K.D.; Schouten, W.E.M.; Veenstra, J.; Brouwer, C.J.; Geerders, G.E.; Hoeksema, K.; Kleene, M.J.; Knapen, M.; Meche, I.B. van der; Mulder-Seeleman, E.; Toonen, A.J.M.; Wijnands, S.; Crevel, R. van; Dofferhoff, A.S.M.; Hofstede, H.J.M. ter; Hoogerwerf, J.; Keuter, M.; Richel, O.; Albers, M.; Grintjes-Huisman, K.J.T.; Haan, M. de; Marneef, M.; Strik-Albers, R.; Rahamat-Langendoen, J.; Stelma, E.E.; Burger, D.; Gisolf, E.H.; Hassing, R.J.; Claassen, M.; Beest, G. ter; Bentum, P.H.M. van; Langebeek, N.; Tiemessen, R.; Swanink, C.M.A.; Lelyveld, S.F.L. van; Soetekouw, R.; Prijt, L.M.M. van der; Swaluw, J. van der; Bermon, N.; Jansen, R.; Herpers, B.L.; Veenendaal, D.; Verhagen, D.W.M.; Wijk, M. van; Bierman, W.F.W.; Bakker, M. & Kleinnij (2019), Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM, AIDS 33(5): 833-844.
- Gast, K.B.; Hoeven, A. van der; Boer, M.G.J. de; Esser, J.W.J. van; Kuijper, E.J.; Verweij, J.J.; Keulen, P.H.J. van & Beek, M.T. van der (2019), Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands, Medical Mycology Case Reports 24: 5-8.
- Scheper, H.; Derogee, R.; Mandad, R.; Wal, R.J.P. van der; Nelissen, R.G.H.H.; Visser, L.G. & Boer, M.G.J. de (2019), A mobile app for postoperative wound care after arthroplasty: Ease of use and perceived usefulness, International Journal of Medical Informatics 129: 75-80.
- Norgaard, S.M.; Jensen, C.S.; Aalestrup, J.; Vandenbroucke-Grauls, C.M.J.E.; Boer, M.G.J. de & Pedersen, A.B. (2019), Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review, Antimicrobial Resistance and Infection Control 8(1).
- Peppel, R.J. van de & Boer, M.G.J. de (2019), The Complex Case of Aspergillus and Mortality, Clinical Infectious Diseases 68(3): 531-532.
- Gast, K.B.; Hoeven, A. van der; Boer, M.G.J. de; Esser, J.W.J. van; Kuijper, E.J.; Verweij, J.J.; Keulen, P.H.J. van & Beek, M.T. van der (2019), Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands, Medical Mycology Case Reports 24: 5-8.
- Lambregts, M.M.C.; Bernards, A.T.; Visser, L.G. & Boer, M.G.J. de (2018), Re: 'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' by Rottier, et al., Clinical Microbiology and Infection 24(12): 1346-1348.
- Boer, M.G.J. de; Walzer, P.D. & Mori, S. (2018), Healthcare related transmission of Pneumocystis pneumonia: From key insights toward comprehensive prevention, Transplant Infectious Disease 20(5).
- Peppel, R.J. van de; Visser, L.G.; Dekkers, O.M. & Boer, M.G.J. de (2018), The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review, Journal of Infection 76(6): 550-562.
- Van der Hoeven A., Akerboom S., Norbart I., Van der Beek M. T., De Boer M. G. J. & Kuijper E. J. (2018), A fatal case of Emergomyces pasteurianus pulmonary infection in an immunocompromised patient with concomitant listeriosis and invasive aspergillosis, Medical Mycology 56: S103-S103.
- Grootveld, R. van; Bilsen, M.P.; Boelsums, T.L.; Heddema, E.R.; Groeneveld, G.H.; Gooskens, J. & Boer, M.G.J. de (2018), Chlamydia caviae Causing Community-Acquired Pneumonia: An Emerging Zoonosis, Vector-Borne and Zoonotic Diseases.
- Scheper, H.; Holten, N. van; Hovens, J.G.F.M. & Boer, M.G.J. de (2018), Severe depression as a neuropsychiatric side effect induced by dolutegravir, HIV Medicine 19(4): E58-E59.
- Dijk, S.T. van; Bos, K.; Boer, M.G.J. de; Draaisma, W.A.; Enst, W.A. van; Felt, R.J.F.; Klarenbeek, B.R.; Otte, J.A.; Puylaert, J.B.C.M.; Geloven, A.A.W. van & Boermeester, M.A. (2018), A systematic review and meta-analysis of outpatient treatment for acute diverticulitis, International Journal of Colorectal Disease 33(5): 505-512.
- Lambregts, M.M.C.; Warreman, E.B.; Bernards, A.T.; Veelken, H.; Borne, P.A.V.; Dekkers, O.M.; Visser, L.G. & Boer, M.G. de (2018), Distribution and clinical determinants of time-to-positivity of blood cultures in patients with neutropenia, European Journal of Haematology 100(2): 206-214.
- Scheper, H.; Hooven, D. van; Sande, M. van de; Wal, R. van der; Beek, M. van der; Visser, L.; Boer, M. de & Nelissen, R. (2018), Outcome of acute staphylococcal prosthetic joint infection treated with debridement, implant retention and antimicrobial treatment with short duration of rifampicin, Journal of Infection 76(5): 498-500.
- Lambregts, M.M.C.; Bernards, A.T.; Visser, L.G. & Boer, M.G.J. de (2018), Re: 'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' by Rottier, et al., Clinical Microbiology and Infection 24(12): 1346-1348.
- Lambregts, M.M.C.; Bernards, A.T.; Visser, L.G. & Boer, M.G.J. de (2018), Re: 'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' by Rottier, et al., Clinical Microbiology and Infection 24(12): 1346-1348.
- Boer, M.G.J. de; Walzer, P.D. & Mori, S. (2018), Healthcare related transmission of Pneumocystis pneumonia: From key insights toward comprehensive prevention, Transplant Infectious Disease 20(5).
- Ruiter, R.; Wunderink, H.F.; Veenendaal, R.A.; Visser, L.G. & Boer, M.G.J. de (2017), Helicobacter pylori resistance in the Netherlands: a growing problem?, Netherlands Journal of Medicine 75(9): 394-398.
- Peppel, R.J. van de; Borne, P.A. von dem; Cessie, S. le & Boer, M.G.J. de (2017), A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short-but not on long-term survival of patients with AML or high-risk MDS, Bone Marrow Transplantation 52(6): 883-888.
- Henegouwen, J.M.V.; Groeneveld, G.H.; Boer, M.G.J. de & Visser, L.G. (2017), A more restrictive use of quinolones in patients with community acquired pneumonia is urgently needed, Netherlands Journal of Medicine 75(10): 462-463.
- Boer, M.G.J. de & Brinkman, K. (2017), Recent observations on intolerance of dolutegravir: differential causes and consequences, AIDS 31(6): 868-870.
- Halem, K. van; Vrolijk, L.; Pereira, A.M. & Boer, M.G.J. de (2017), Characteristics and Mortality of Pneumocystis Pneumonia in Patients With Cushing's Syndrome: A Plea for Timely Initiation of Chemoprophylaxis, Open Forum Infectious Diseases 4(1).
- Rump, B.; Boer, M. de; Reis, R.; Wassenberg, M. & Steenbergen, J. van (2017), Signs of stigma and poor mental health among carriers of MRSA, Journal of Hospital Infection 95(3): 268-274.
- Bolhuis, H. van; Wolters, M.; Boer, M. de; Fijnheer, R.; Langhout, M.V.; Niphuis, H. & Eckmann, C. (2017), Thrombotic thrombocytopenic purpura related to ADAMTS13 deficiency, and successful treatment in a chimpanzee (Pan troglodytes verus), Journal of Medical Primatology 46(5): 267-270.
- Boer, M.G.J. de; Berk, G.E.L. van den; Holten, N. van; Oryszcyn, J.E.; Dorama, W.; Moha, D.A. & Brinkman, K. (2016), Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice, AIDS 30(18): 2831-2834.
- Creemers-Schild, D.; Kroon, F.P.; Kuijper, E.J. & Boer, M.G.J. de (2016), Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study, Infection 44(3): 291-299.
- Creemers-Schild, D.; Kroon, F.P.; Kuijper, E.J. & Boer, M.G.J. de (2016), Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole, Infection 44(3): 291-299.
- Boer, M.C.; Prins, C.; Meijgaarden, K.E. van; Dissel, J.T. van; Ottenhoff, T.H.M. & Joosten, S.A. (2015), Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults, Clinical and Vaccine Immunology 22(7): 778-788.
- Peppel, R.J. van de; Borne, P.A.V.; Cessie, S. le & Boer, M.G.J. de (2015), A new time dependent analytical approach for assessment of the impact of Invasive Aspergillosis on short and long-term survival, Mycoses 58: 156-157.
- Boer, M.G.J. de; Halkes, C.J.M. & Vosse, E.V. de (2014), PTX3 Deficiency and Aspergillosis, New England Journal of Medicine 370(17): 1665-1666.
- Diepen, A.T.N. van; Hoekstra, T.; Rotmans, J.I.; Boer, M.G.J. de; Cessie, S. le; Suttorp, M.M.; Struijk, D.G.; Boeschoten, E.W.; Krediet, R.T. & Dekker, F.W. (2014), The association between dialysis modality and the risk for dialysis technique and non-dialysis technique-related infections, Nephrology Dialysis Transplantation 29(12): 2244-2250.
- Peppel, R.J. van de; Dekkers, O.M.; Borne, P.A. von dem & Boer, M.G.J. de (2014), Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome, Medical Mycology 52(7): 699-705.
- Knoester, M.; Boer, M.G.J. de; Maarleveld, J.J.; Claas, E.C.J.; Bernards, A.T.; Jonge, E.; Dissel, J.T. van & Veldkamp, K.E. (2014), An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Clinical Microbiology and Infection 20(4): O207-O215.
- Diepen, A.T. van; Hoekstra, T.; Rotmans, J.I.; Boer, M.G. de; Lecessie, S.; Suttorp, M.M.; Struijk, D.G.; Boeschoten, E.W.; Krediet, R.T. & Dekker, F.W. (2014), FIRST DIALYSIS MODALITY AND THE RISK FOR DIALYSIS TECHNIQUE AND NON-DIALYSIS TECHNIQUE RELATED INFECTIONS, Nephrology Dialysis Transplantation 29: 274-274.
- Knoester, M.; Boer, M.G.J. de; Maarleveld, J.J.; Claas, E.C.J.; Bernards, A.T.; Jonge, E.; Dissel, J.T. van & Veldkamp, K.E. (2014), An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Clinical Microbiology and Infection 20(4): O207-O215.
- Boer, M.G.J. de (2012), Linking Pneumocystis Epidemiology, Transmission, and Virulence.
- Boer, M.G.J. de (2012), Linking Pneumocystis Epidemiology, Transmission, and Virulence, Clinical Infectious Diseases 54(10): 1445-1447.
- Boer, M.G.J. de; Gelinck, L.B.S.; Zelst, B.D. van; Sande, W.W.J. van de; Willems, L.N.A.; Dissel, J.T. van; Jonge, R. de & Kroon, F.P. (2011), beta-D-Glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative Patients: A prospective study, Journal of Infection 62(1): 93-100.
- Chai, L.Y.A.; Boer, M.G.J. de; Velden, W.J.F.M. van der; Plantinga, T.S.; Spriel, A.B. van; Jacobs, C.; Halkes, C.J.M.; Vonk, A.G.; Blijlevens, N.M.; Dissel, J.T. van; Donnelly, P.J.; Kullberg, B.J.; Maertens, J. & Netea, M.G. (2011), The Y238X Stop Codon Polymorphism in the Human beta-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis, Journal of Infectious Diseases 203(5): 736-743.
- Boer, M.G.J. de; Zelst, B. van; Gelinck, L.B.S.; Kroon, F.P. & Jonge, R. de (2011), Pneumocystis pneumonia and measurement of S-adenosylmethionine plasma levels, Journal of Infection 62(6): 493-495.
- Boer, M.G.J. de; Kroon, F.P.; Cessie, S. le; Fijter, J.W. de & Dissel, J.T. van (2011), Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
- Lupetti, A.; Boer, M.G.J. de; Erba, P.; Campa, M. & Nibbering, P.H. (2011), Radiotracers for fungal infection imaging, Medical Mycology 49: S62S69.
- Boer, M.G.J. de; Fijter, J.W. de & Kroon, F.P. (2011), Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review, Medical Mycology 49(7): 673-680.
- Boer, M.G.J. de; Jolink, H.; Halkes, C.J.M.; Heiden, P.L.J. van der; Kremer, D.; Falkenburg, J.H.F.; Vosse, E. van de & Dissel, J.T. van (2011), Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation, PLoS ONE 6(4).
- Boer, M.G.J. de; Fijter, J.W. de & Kroon, F.P. (2011), Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review., Medical Mycology 49(7): 673-80.
- Boer, M.G.J. de; Zelst, B. van; Gelinck, L.B.S.; Kroon, F.P. & Jonge, R. de (2011), Pneumocystis pneumonia and measurement of S-adenosylmethionine plasma levels.
- Boer, M.G.J. de; Kroon, F.P.; Cessie, S. le; Fijter, J.W. de & Dissel, J.T. van (2011), Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis., Transplant Infectious Disease.
- Boer, M.G.J. de; Gelinck, L.B.S.; Zelst, B.D. van; Sande, W.W.J. van de; Willems, L.N.A.; Dissel, J.T. van; Jonge, R. de & Kroon, F.P. (2011), β-D-glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study.
- Chai, L.Y.A.; Boer, M.G.J. de; Velden, W.J.F.M. van der; Plantinga, T.S.; Spriel, A.B. van; Jacobs, C.; Halkes, C.J.M.; Vonk, A.G.; Blijlevens, N.M.; Dissel, J.T. van; Donnelly, P.J.; Kullberg, B.J.; Maertens, J. & Netea, M.G. (2011), The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis, The Journal of Infectious Diseases 203(5): 736-743.
- Boer, M.G.J. de; Wessels, E.; Claas, E.C.J. & Kroon, F.P. (2010), Potential Influence of More-Sensitive HIV-1 Load Detection by the new Roche Cobas AmpliPrep/Cobas TaqMan Version 2.0 Assay on Clinical Management of HIV-Positive Pregnant Women, Journal of Clinical Microbiology 48(11): 4301-4302.
- de Boer MGJ, Brunsveld-Reinders AH, Salomons EMA, Dijkshoorn L, Bernards AT, van den Berg PCM & van den Broek PJ (2008), Multifactorial origin of high incidence of Serratia marcescens in a cardio-thoracic ICU: Analysis of risk factors and epidemiological characteristics, Journal of Infection 56(6).
- Boer, M.G.J. de; Brunsveld-Reinders, A.H.; Salomons, E.M.A.; Dijkshoorn, L.; Bernards, A.T.; Berg, P.C.M. van den & Broek, P.J. van den (2008), Multifactorial origin of high incidence of Serratia marcescens in a cardio-thoracic ICU:: Analysis of risk factors and epidemiological characteristics, Journal of Infection 56(6): 446-453.
- de Boer MGJ, van Coppenraet LESB, Gaasbeek A, Berger SP, Gelinck LBS, van Houwelingen HC, van den Broek P, Kuijper EJ, Kroon FP & Vandenbroucke JP (2007), An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: Interhuman transmission or a common environmental source?, Clinical Infectious Diseases 44(9).
- Boer, M.G.J. de; Lambregts, P.C.L.A.; Dam, A.P. van & van't Wout, J.W. (2007), Meningitis caused by Capnocytophaga canimorsus:: When to expect the unexpected, Clinical Neurology and Neurosurgery 109(5): 393-398.
- Boer, M.G.J. de; Coppenraet, L.E.S.B. van; Gaasbeek, A.; Berger, S.P.; Gelinck, L.B.S.; Houwelingen, H.C. van; Broek, P. van den; Kuijper, E.J.; Kroon, F.P. & Vandenbroucke, J.P. (2007), An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients:: Interhuman transmission or a common environmental source?, Clinical Infectious Diseases 44(9): 1143-1149.
- Grunhagen, D.J.; Boer, M.G.J. de; Beaufort, A.J. de & Walther, F.J. (2002), Transepidermal water loss during halogen spotlight phototherapy in preterm infants, Pediatric Research 51(3).
- Grunhagen, D.J.; Boer, M.G.J. de; Beaufort, A.J. de & Walther, F.J. (2000), How much extra fluid intake is necessary during halogen spotlight phototherapy in preterm infants?, Pediatric Research 47(4): 288A-288A.
- Lid COIG (Cursorisch Onderwijs Interne Geneeskunde) infectieziekten (onderwijs)